Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I

BACKGROUND. Although the prevalence of non-AIDS-defining cancers (non-ADCs) among people living with HIV is rising, we observed HIV testing rates below 5% at our oncology center, against a regional HIV prevalence of 0.2%–0.4%. We performed the Investigating Barriers in HIV-Testing Oncology Patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Merz, Laurent, Zimmermann, Stefan, Peters, Solange, Cavassini, Matthias, Darling, Katharine E.A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AlphaMed Press 2016
Pynciau:
Community Outreach
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061530/
https://ncbi.nlm.nih.gov/pubmed/27440062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0107
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg